CS logo
small CS logo
KLB Gesundheitsforschung Lübeck GmbH

Lubeck, Germany
Research institute in Lübeck, Schleswig-Holstein
Sandstraße 18, 23552 Lübeck

About KLB Gesundheitsforschung Lübeck GmbH


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
6
AbbVie
1
Ionis Pharmaceuticals, Inc.
1
Johannes Gutenberg University Mainz
1
Total Rows: 4

Clinical Trials at KLB Gesundheitsforschung Lübeck GmbH


During the past decade, KLB Gesundheitsforschung Lübeck GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22221100002211110000000033001111Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma
2015-06-26
2017-03-09
Terminated
54
Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
2015-06-23
2018-02-02
Completed
214
Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD
2016-01-25
2016-06-14
Completed
120
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
2016-04-13
2021-06-14
Completed
464
Cardiovascular Function in COPD Patients
2017-03-29
2018-03-26
Completed
76
A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
2020-01-08
2020-09-29
Completed
213
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
2020-12-22
2021-08-09
Terminated
60
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
2021-03-04
2022-01-19
Completed
7

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "KLB Gesundheitsforschung Lübeck GmbH" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 6Boehringer Ingelheim: 6AbbVie: 1AbbVie: 1Ionis Pharmaceuticals, Inc.: 1Ionis Pharmaceuticals, Inc.: 1Johannes GutenbergUniversity Mainz: 1Johannes GutenbergUniversity Mainz: 1

Created with Highcharts 11.1.0Top CollaboratorsBoehringer Ingelheim: 1Boehringer Ingelheim: 1German FederalMinistry of Educationand Research: 1German FederalMinistry of Educationand Research: 1

Clinical Trials Conditions at KLB Gesundheitsforschung Lübeck GmbH


According to Clinical.Site data, the most researched conditions in "KLB Gesundheitsforschung Lübeck GmbH" are "Pulmonary Disease, Chronic Obstructive" (4 trials), "Asthma" (2 trials), "Bronchiectasis" (1 trials), "Chronic Bronchitis" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "KLB Gesundheitsforschung Lübeck GmbH" in a lesser frequency.

Clinical Trials Intervention Types at KLB Gesundheitsforschung Lübeck GmbH


Most popular intervention types in "KLB Gesundheitsforschung Lübeck GmbH" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 1026706" (1 trials), "BI 1291583" (1 trials), "BI 1323495" (1 trials) and "Fluticasone propionate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at KLB Gesundheitsforschung Lübeck GmbH


The vast majority of trials in "KLB Gesundheitsforschung Lübeck GmbH" are 9 trials for "All" genders.

Clinical Trials Status at KLB Gesundheitsforschung Lübeck GmbH


Currently, there are NaN active trials in "KLB Gesundheitsforschung Lübeck GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in KLB Gesundheitsforschung Lübeck GmbH, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in KLB Gesundheitsforschung Lübeck GmbH, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Phase 4: 3Phase 4: 3Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1